JP2016507520A5 - - Google Patents

Download PDF

Info

Publication number
JP2016507520A5
JP2016507520A5 JP2015555242A JP2015555242A JP2016507520A5 JP 2016507520 A5 JP2016507520 A5 JP 2016507520A5 JP 2015555242 A JP2015555242 A JP 2015555242A JP 2015555242 A JP2015555242 A JP 2015555242A JP 2016507520 A5 JP2016507520 A5 JP 2016507520A5
Authority
JP
Japan
Prior art keywords
polypeptide
amino acid
hbc
seq
vlp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015555242A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016507520A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/012586 external-priority patent/WO2014116730A2/en
Publication of JP2016507520A publication Critical patent/JP2016507520A/ja
Publication of JP2016507520A5 publication Critical patent/JP2016507520A5/ja
Pending legal-status Critical Current

Links

JP2015555242A 2013-01-23 2014-01-22 安定化されたb型肝炎コアポリペプチド Pending JP2016507520A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361755850P 2013-01-23 2013-01-23
US61/755,850 2013-01-23
US201361901243P 2013-11-07 2013-11-07
US61/901,243 2013-11-07
PCT/US2014/012586 WO2014116730A2 (en) 2013-01-23 2014-01-22 Stabilized hepatitis b core polypeptide

Publications (2)

Publication Number Publication Date
JP2016507520A JP2016507520A (ja) 2016-03-10
JP2016507520A5 true JP2016507520A5 (enExample) 2017-03-30

Family

ID=51228185

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015555242A Pending JP2016507520A (ja) 2013-01-23 2014-01-22 安定化されたb型肝炎コアポリペプチド

Country Status (5)

Country Link
US (1) US9896483B2 (enExample)
EP (1) EP2948469A4 (enExample)
JP (1) JP2016507520A (enExample)
CA (1) CA2936092A1 (enExample)
WO (1) WO2014116730A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2936092A1 (en) 2013-01-23 2014-07-31 The Board Of Trustees Of The Leland Stanford Junior University Stabilized hepatitis b core polypeptide
DE16703049T1 (de) * 2015-01-15 2018-07-12 University Of Copenhagen Virusähnliche partikel mit effizienter epitopanzeige
DK3368068T3 (da) 2015-10-30 2021-02-22 Univ Copenhagen Viruslignende partikler med effektiv epitopdisplay
CN106636016B (zh) * 2017-02-24 2020-03-17 天津大学 一种通过正负电荷引入辅助病毒样颗粒自组装的方法和应用
WO2019115635A1 (en) * 2017-12-13 2019-06-20 Curevac Ag Flavivirus vaccine
WO2020139843A1 (en) * 2018-12-28 2020-07-02 The Board Of Trustee Of The Leland Stanford Junior University Engineered hepatitis b core polypeptide
CN109666067A (zh) * 2019-01-07 2019-04-23 中国科学院过程工程研究所 一种重组病毒样颗粒及其制备方法和用途
WO2020145901A1 (en) * 2019-01-11 2020-07-16 Agency For Science, Technology And Research Use of hla-a*11:01-restricted hepatitis b virus (hbv) peptides for identifying hbv-specific cd8+ t cells

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994008601A1 (en) 1992-10-14 1994-04-28 The Board Of Trustees Of The Leland Stanford Junior University Enhancement of b cell lymphoma tumor resistance using idiotype/cytokine conjugates
US6239116B1 (en) 1994-07-15 2001-05-29 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
EP1167378B1 (en) 1994-07-15 2011-05-11 University of Iowa Research Foundation Immunomodulatory oligonucleotides
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6429199B1 (en) 1994-07-15 2002-08-06 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules for activating dendritic cells
US5968767A (en) 1996-06-07 1999-10-19 Genentech, Inc. Methods for in vitro protein synthesis
US6593103B1 (en) 1997-02-07 2003-07-15 The Regents Of The University Of California HIV capsid assembly-associated compositions and method
US6406705B1 (en) 1997-03-10 2002-06-18 University Of Iowa Research Foundation Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
DE69819150T3 (de) 1997-06-06 2007-12-20 Dynavax Technologies Corp., San Diego Immunstimulierende oligonucleotide, zusammensetzungen davon, und verfahren zur verwendung davon
CA2320488C (en) * 1998-02-12 2007-03-06 Immune Complex, Corporation Strategically modified hepatitis b core proteins and their derivatives
AU770802B2 (en) 1998-10-21 2004-03-04 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Virus-like particles for the induction of autoantibodies
SK7602001A3 (en) * 1998-12-04 2002-03-05 Biogen Inc Hbv core antigen particles with multiple immunogenic components attached via peptide ligands
US6994986B2 (en) 1999-03-17 2006-02-07 The Board Of Trustees Of The Leland Stanford University In vitro synthesis of polypeptides by optimizing amino acid metabolism
US6168931B1 (en) 1999-03-17 2001-01-02 The Board Of Trustees Of The Leland Stanford Junior University Enhanced in vitro synthesis of biological macromolecules using a novel ATP regeneration system
US6337191B1 (en) 1999-03-22 2002-01-08 The Board Of Trustees Of The Leland Stanford Junior University Vitro protein synthesis using glycolytic intermediates as an energy source
US6586207B2 (en) 2000-05-26 2003-07-01 California Institute Of Technology Overexpression of aminoacyl-tRNA synthetases for efficient production of engineered proteins containing amino acid analogues
US6548276B2 (en) 2000-09-06 2003-04-15 The Board Of Trustees Of The Leland Stanford Junior University Enhanced in vitro synthesis of active proteins containing disulfide bonds
US7041479B2 (en) 2000-09-06 2006-05-09 The Board Of Trustess Of The Leland Stanford Junior University Enhanced in vitro synthesis of active proteins containing disulfide bonds
DK2322631T3 (en) 2001-04-19 2015-01-12 Scripps Research Inst Methods and compositions for the production of orthogonal tRNA-aminoacyl-tRNA syntetasepar
EP1450856B1 (en) 2001-09-14 2009-11-11 Cytos Biotechnology AG Packaging of immunostimulatory cpg into virus-like particles: method of preparation and use
AU2002366710A1 (en) 2001-12-20 2003-07-09 The Government Of The United States Of America As Represented By The Secretary Of The Department Of USE OF CpG OLIGODEOXYNUCLEOTIDES TO INDUCE ANGIOGENESIS
US8466116B2 (en) 2001-12-20 2013-06-18 The Unites States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of CpG oligodeoxynucleotides to induce epithelial cell growth
CA2487424C (en) 2002-05-30 2011-01-04 The Scripps Research Institute Copper-catalysed ligation of azides and acetylenes
PT1539948E (pt) 2002-08-19 2010-01-20 Univ Leland Stanford Junior Métodos melhorados para a síntese de proteínas in vitro
DE60333370D1 (de) * 2002-09-06 2010-08-26 Advanced Life Science Inst Inc Zur bildung von partikeln fähiges hbv-precore-protein
PT1897548E (pt) 2003-02-28 2013-11-19 Univ Johns Hopkins Regulação de células t
MXPA05009289A (es) 2003-03-26 2005-10-18 Cytos Biotechnology Ag Conjugados de particulas tipo virus del analogo del peptido melan-a.
CN102618605B (zh) 2003-06-18 2015-09-02 斯克利普斯研究院 非天然活性氨基酸遗传密码增加
WO2005005614A2 (en) * 2003-07-03 2005-01-20 Pecos Labs, Inc. Combined b-cell and t-cell epitopes on vlp for improved vaccines
US20050054044A1 (en) 2003-07-18 2005-03-10 The Board Of Trustees Of The Leland Stanford Junior University Method of alleviating nucleotide limitations for in vitro protein synthesis
US7341852B2 (en) 2003-07-18 2008-03-11 The Board Of Trustees Of The Leland Stanford Junior University Methods of decoupling reaction scale and protein synthesis yield in batch mode
US8119340B2 (en) 2003-10-08 2012-02-21 The Feinstein Institute For Medical Research Methods and compositions for diagnosis and treatment of B cell chronic lymphocytic leukemia
AU2004293798B2 (en) 2003-11-20 2008-10-23 The Board Of Trustees Of The Leland Stanford Junior University Improved methods of in vitro protein synthesis
US20050170551A1 (en) 2004-02-04 2005-08-04 Strip David R. Manufacture of flat panel light emitting devices
CA2567741A1 (en) * 2004-05-25 2006-03-30 Chimeracore, Inc. Self-assembling nanoparticle drug delivery system
ES2519444T3 (es) 2004-09-21 2014-11-07 The Scripps Research Institute Incorporación in vivo de alquinil aminoácidos a proteínas en eubacterias
WO2006065751A2 (en) 2004-12-13 2006-06-22 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Cpg oligonucleotide prodrugs, compositions thereof and associated therapeutic methods
AU2007348315A1 (en) * 2006-04-07 2008-09-12 Chimeros, Inc. Compositions and methods for treating B- cell malignancies
US20080096819A1 (en) 2006-05-02 2008-04-24 Allozyne, Inc. Amino acid substituted molecules
WO2008002663A2 (en) 2006-06-28 2008-01-03 The Board Of Trustees Of The Leland Stanford Junior University Immunogenic protein constructs
CA2657811C (en) 2006-06-29 2014-10-21 The Board Of Trustees Of The Leland Stanford Junior University Cell-free synthesis of proteins containing unnatural amino acids
WO2008002673A2 (en) 2006-06-29 2008-01-03 The Board Of Trustees Of The Leland Stanford Junior University Cell-free synthesis of virus like particles
NZ574960A (en) 2006-09-08 2012-02-24 Ambrx Inc Suppressor trna transcription in vertebrate cells
US7871794B2 (en) 2007-01-18 2011-01-18 The Board Of Trustees Of The Leland Stanford Junior University Enhanced cell-free synthesis of active proteins containing disulfide bonds
CA2707840A1 (en) 2007-08-20 2009-02-26 Allozyne, Inc. Amino acid substituted molecules
US8445706B2 (en) 2008-09-05 2013-05-21 Board Of Trustees Of Northern Illinois University Unnatural amino acids capable of covalently modifying protein phosphatases and their use as general and specific inhibitors and probes
WO2010042755A2 (en) * 2008-10-08 2010-04-15 Chimeros Inc. Chimeric therapeutics, compositions, and methods for using same
US20100168402A1 (en) 2008-11-14 2010-07-01 Bundy Bradley C Direct Attachment of Polypeptides to Virus Like Particles
US8324149B2 (en) 2008-11-18 2012-12-04 The Board Of Trustees Of The Leland Stanford Junior University Encapsidation of heterologous entities into virus-like particles
GB2498323B8 (en) 2009-11-05 2014-08-06 Hal Padgett Generation of antigenic virus-like particles through protein-protein linkages
WO2011109422A2 (en) 2010-03-02 2011-09-09 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Compositions and methods for the treatment of cancer
JP2014527072A (ja) * 2011-09-09 2014-10-09 バイオメド リアルティー, エル.ピー. ウイルスタンパク質の集合を制御するための方法および組成物
CA2863658C (en) 2012-02-03 2023-03-14 Emory University Immunostimulatory compositions, particles, and uses related thereto
CA2936092A1 (en) 2013-01-23 2014-07-31 The Board Of Trustees Of The Leland Stanford Junior University Stabilized hepatitis b core polypeptide
JP2016515538A (ja) 2013-03-15 2016-05-30 ブレット バイオテクノロジー、 インク.Bullet Biotechnology, Inc. 特異的な多価ウイルス様粒子ワクチンおよびその使用
EP3079717A1 (en) 2013-12-09 2016-10-19 Bullet Biotechnology, Inc. Specific virus-like particle-cpg oligonucleotide vaccines and uses thereof

Similar Documents

Publication Publication Date Title
JP2016507520A5 (enExample)
JP2015531407A5 (enExample)
JP2012095652A5 (enExample)
MX2019004499A (es) Sistemas de replicón de virus recombinante y usos de estos.
RU2012122173A (ru) Варианты альбумина
RU2010108308A (ru) Способ получения гетерогенных белков
JP2019530466A5 (enExample)
JP2014221052A5 (enExample)
RU2014101401A (ru) Антигены вируса гриппа h1n1 с широким спектром активности, оптимизированные с применением вычислительных средств
DK1885850T3 (da) Fremgangsmåde til fremstilling af D-psicose ved D-psicose-epimerase
RU2011128371A (ru) Модифицированные f протеины sv и способы их применения
JP2007197439A5 (enExample)
ZA202100386B (en) Influenza virus hemagglutinin mutants
JP2020509751A5 (enExample)
JP2007513634A5 (enExample)
JP2014524241A5 (enExample)
JP2011152137A5 (enExample)
JP2020528760A (ja) 新規融合タンパク質の調製およびそのタンパク質合成の向上における使用
BRPI0417159A (pt) produção de partìcula semelhante a vìrus icosaédrico recombinante em pseudomÈnades
CA2567254A1 (en) Tc-83-derived alphavirus vectors, particles and methods
JP2009268467A5 (enExample)
RU2014142785A (ru) Оптимизированные с помощью вычислительных средств антигены с широким спектром реактивности для вирусов гриппа h5n1 и h1n1
JP2022062113A5 (enExample)
WO2006119516A3 (en) Expression of viral proteins in plants
JP2014076042A5 (enExample)